NLRP3 and neurodegenerative disease: Indeed, there are numerous disease states in which NRF2 activation and NLRP3 inhibition are known to be beneficial including neurodegenerative diseases, metabolic diseases, gastrointestinal diseases, and autoimmune disorders.